This podcast is brought to you by:

Sandy Solmon wears several hats, she leads a private, emerging medical technology company that develops stem cell-based regenerative therapies for the treatment of CNS disorders and she is CEO, chief innovator, and founder of Sweet Street Desserts, the world’s largest manufacturer of frozen gourmet desserts. From R&D to regulations, she discusses how running a global food company translates to an emerging biotech company.

Download Transcript